Our applications

Our platform is a powerful tool in the fight against various types of cancer. By accurately profiling Circulating Tumor Cells (CTCs), our technology guides the use of targeted therapies, such as Antibody Drug Conjugates (ADCs), leading to improved patient outcomes and reduced healthcare costs across a broad spectrum of cancers.

Beyond oncology, Optosense’s technology is highly adaptable for managing chronic diseases. By monitoring circulating cells in the bloodstream, our platform provides vital data that can be used to optimize long-term treatment plans for conditions such as cardiovascular diseases, sepsis, and autoimmune disorders, ensuring consistent and personalized care.

At the forefront of personalized medicine, Optosense offers tools that enable clinicians to tailor treatment plans based on the unique profiles of individual patients. Whether in oncology or chronic disease management, our technology supports a more personalized approach to healthcare, enhancing the effectiveness of treatments and improving the overall patient experience.